Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease
Every year almost half of the fourteen thousand patients who have received bone marrow or stem cell transplants will develop chronic graft-versus-host disease (cGVHD). Currently, there are no options…